icon
EquitySector - Healthcare

Nippon India Pharma Fund - Growth

3Y Annualised

18.28%

-0.57% 1D

Fund Performance

Fund Multiplier

Fund Info

Peer Comparison

Fund Managers

AMC Details

Performance

Annualised

-4.48%

-0.57% 1D

Benchmark

N/A

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

This Fund

4 years 2 months

NIFTY 50

6 years 4 months

FD

9 years 7 months

Fund info

Fund size

₹7637.04 Cr

Min. SIP amount

₹100

Min. Lumpsum amount

₹5000

Exit load

0.01%

1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units. Nil, thereafter.

Risk Profile

Very High Risk

Fund Managers

SRB
Sailesh Raj BhanFund Manager Since 1 Apr 2005
KD
Kinjal DesaiFund Manager Since 25 May 2018

About Nippon India Pharma Fund - Growth

Nippon India Pharma Fund - Growth is a Equity mutual fund scheme from Nippon Life India Asset Management Ltd. This fund has been in existence for 20 years, having been launched on 2004-06-05. Nippon India Pharma Fund - Growth has ₹7637.04 Cr worth of assets under management (AUM) as of Wed Mar 12 2025. The latest Net Asset Value (NAV) of Nippon India Pharma Fund - Growth as of Tue Mar 11 2025 is ₹464.6458. The fund has an expense ratio of 1.82%, which is medium comparable to most other Equity funds.

Nippon India Pharma Fund - Growth returns for the last 1 year are 8.62%. Since launch, it has delivered 20.32% average annual returns.

The Nippon India Pharma Fund - Growth has the majority of its money invested in Healthcare sectors.

Top 5 Holdings of Nippon India Pharma Fund - Growth.

  1. Sun Pharmaceuticals Industries Ltd: 13.68%
  2. Divi's Laboratories Ltd: 9.32%
  3. Lupin Ltd: 7.73%
  4. Cipla Ltd: 5.90%
  5. Dr Reddy's Laboratories Ltd: 5.35%

AMC Information

NameNippon Life India Asset Management Ltd
Founding Date2004-06-05
Emailcustomercare@nipponindiaim.in
Phone022-6808 7000/18602660111
Websitehttps://mf.nipponindiaim.com/
AddressNippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W)

Tax Implications of Nippon India Pharma Fund - Growth

Short Term Gains20% + applicable Surcharge + 4% Cess
Long Term Gains12.5% without indexation + applicable Surcharge + 4% Cess

Similar Funds from Nippon Life India Asset Management Ltd

Calculate Your Returns

Estimated Returns in 3 Years

₹0

Total Amount

₹0

Invest Nowcta image

FAQs

View All

It’s Time to Grow Your Wealth

₹1,000+ cr

AUM

1+ Lac

Investors

stack mb